|
US3687808A
(en)
|
1969-08-14 |
1972-08-29 |
Univ Leland Stanford Junior |
Synthetic polynucleotides
|
|
US4162282A
(en)
|
1976-04-22 |
1979-07-24 |
Coulter Electronics, Inc. |
Method for producing uniform particles
|
|
US4310505A
(en)
|
1979-11-08 |
1982-01-12 |
California Institute Of Technology |
Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
|
|
US4533254A
(en)
|
1981-04-17 |
1985-08-06 |
Biotechnology Development Corporation |
Apparatus for forming emulsions
|
|
US5030453A
(en)
|
1983-03-24 |
1991-07-09 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
|
US5118800A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
|
US4728575A
(en)
|
1984-04-27 |
1988-03-01 |
Vestar, Inc. |
Contrast agents for NMR imaging
|
|
CA1264668A
(en)
|
1984-06-20 |
1990-01-23 |
Pieter R. Cullis |
Extrusion techniques for producing liposomes
|
|
FR2567892B1
(fr)
|
1984-07-19 |
1989-02-17 |
Centre Nat Rech Scient |
Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
|
|
US5367066A
(en)
|
1984-10-16 |
1994-11-22 |
Chiron Corporation |
Oligonucleotides with selectably cleavable and/or abasic sites
|
|
US4921706A
(en)
|
1984-11-20 |
1990-05-01 |
Massachusetts Institute Of Technology |
Unilamellar lipid vesicles and method for their formation
|
|
FR2575751B1
(fr)
|
1985-01-08 |
1987-04-03 |
Pasteur Institut |
Nouveaux nucleosides de derives de l'adenosine, leur preparation et leurs applications biologiques
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
US4728578A
(en)
|
1986-08-13 |
1988-03-01 |
The Lubrizol Corporation |
Compositions containing basic metal salts and/or non-Newtonian colloidal disperse systems and vinyl aromatic containing polymers
|
|
EP0366685B1
(en)
|
1987-06-24 |
1994-10-19 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Nucleoside derivatives
|
|
US5824311A
(en)
|
1987-11-30 |
1998-10-20 |
Trustees Of The University Of Pennsylvania |
Treatment of tumors with monoclonal antibodies against oncogene antigens
|
|
US4870287A
(en)
|
1988-03-03 |
1989-09-26 |
Loma Linda University Medical Center |
Multi-station proton beam therapy system
|
|
US5175273A
(en)
|
1988-07-01 |
1992-12-29 |
Genentech, Inc. |
Nucleic acid intercalating agents
|
|
DE68912139T2
(de)
|
1988-11-09 |
1994-04-28 |
Colin Tilcock |
Liposomale radiologische kontrastmittel.
|
|
US5134066A
(en)
|
1989-08-29 |
1992-07-28 |
Monsanto Company |
Improved probes using nucleosides containing 3-dezauracil analogs
|
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
|
DE69034150T2
(de)
|
1989-10-24 |
2005-08-25 |
Isis Pharmaceuticals, Inc., Carlsbad |
2'-Modifizierte Oligonukleotide
|
|
US5130302A
(en)
|
1989-12-20 |
1992-07-14 |
Boron Bilogicals, Inc. |
Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same
|
|
US6005087A
(en)
|
1995-06-06 |
1999-12-21 |
Isis Pharmaceuticals, Inc. |
2'-modified oligonucleotides
|
|
US5681941A
(en)
|
1990-01-11 |
1997-10-28 |
Isis Pharmaceuticals, Inc. |
Substituted purines and oligonucleotide cross-linking
|
|
US5646265A
(en)
|
1990-01-11 |
1997-07-08 |
Isis Pharmceuticals, Inc. |
Process for the preparation of 2'-O-alkyl purine phosphoramidites
|
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
|
US5459255A
(en)
|
1990-01-11 |
1995-10-17 |
Isis Pharmaceuticals, Inc. |
N-2 substituted purines
|
|
GB9009980D0
(en)
|
1990-05-03 |
1990-06-27 |
Amersham Int Plc |
Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
|
|
ES2116977T3
(es)
|
1990-05-11 |
1998-08-01 |
Microprobe Corp |
Soportes solidos para ensayos de hibridacion de acidos nucleicos y metodos para inmovilizar oligonucleotidos de modo covalente.
|
|
JPH0874B2
(ja)
|
1990-07-27 |
1996-01-10 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
遺伝子発現を検出および変調するヌクレアーゼ耐性、ピリミジン修飾オリゴヌクレオチド
|
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
|
DE4126983A1
(de)
|
1991-08-15 |
1993-02-18 |
Boehringer Mannheim Gmbh |
Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
|
|
EP0538194B1
(de)
|
1991-10-17 |
1997-06-04 |
Novartis AG |
Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte
|
|
US5594121A
(en)
|
1991-11-07 |
1997-01-14 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
|
AU3222793A
(en)
|
1991-11-26 |
1993-06-28 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
|
|
TW393513B
(en)
|
1991-11-26 |
2000-06-11 |
Isis Pharmaceuticals Inc |
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
|
|
US5484908A
(en)
|
1991-11-26 |
1996-01-16 |
Gilead Sciences, Inc. |
Oligonucleotides containing 5-propynyl pyrimidines
|
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
|
EP0577558A2
(de)
|
1992-07-01 |
1994-01-05 |
Ciba-Geigy Ag |
Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
|
|
US5801029A
(en)
|
1993-02-16 |
1998-09-01 |
Onyx Pharmaceuticals, Inc. |
Cytopathic viruses for therapy and prophylaxis of neoplasia
|
|
US5801005A
(en)
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
|
CA2159631A1
(en)
|
1993-03-30 |
1994-10-13 |
Sanofi |
Acyclic nucleoside analogs and oligonucleotide sequences containing them
|
|
DE4311944A1
(de)
|
1993-04-10 |
1994-10-13 |
Degussa |
Umhüllte Natriumpercarbonatpartikel, Verfahren zu deren Herstellung und sie enthaltende Wasch-, Reinigungs- und Bleichmittelzusammensetzungen
|
|
US5502177A
(en)
|
1993-09-17 |
1996-03-26 |
Gilead Sciences, Inc. |
Pyrimidine derivatives for labeled binding partners
|
|
US5457187A
(en)
|
1993-12-08 |
1995-10-10 |
Board Of Regents University Of Nebraska |
Oligonucleotides containing 5-fluorouracil
|
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5596091A
(en)
|
1994-03-18 |
1997-01-21 |
The Regents Of The University Of California |
Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
|
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
|
US5525711A
(en)
|
1994-05-18 |
1996-06-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Pteridine nucleotide analogs as fluorescent DNA probes
|
|
US5597909A
(en)
|
1994-08-25 |
1997-01-28 |
Chiron Corporation |
Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
|
|
GB9506466D0
(en)
|
1994-08-26 |
1995-05-17 |
Prolifix Ltd |
Cell cycle regulated repressor and dna element
|
|
US6366682B1
(en)
|
1994-11-28 |
2002-04-02 |
Indivos Corporation |
Tokenless electronic transaction system
|
|
CN1178470A
(zh)
|
1995-01-10 |
1998-04-08 |
菲布洛根有限公司 |
用于治疗免疫性疾病的基于胶原的方法和制剂
|
|
US5792747A
(en)
|
1995-01-24 |
1998-08-11 |
The Administrators Of The Tulane Educational Fund |
Highly potent agonists of growth hormone releasing hormone
|
|
GB9507985D0
(en)
|
1995-04-19 |
1995-06-07 |
Orion Yhtymae Oy |
Antibody to aminoterminal propeptide to type 1 procollagen and assay method using it
|
|
US5760395A
(en)
|
1996-04-18 |
1998-06-02 |
Universities Research Assoc., Inc. |
Method and apparatus for laser-controlled proton beam radiology
|
|
US5739169A
(en)
|
1996-05-31 |
1998-04-14 |
Procept, Incorporated |
Aromatic compounds for inhibiting immune response
|
|
US20080119427A1
(en)
|
1996-06-06 |
2008-05-22 |
Isis Pharmaceuticals, Inc. |
Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation
|
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
|
US5891467A
(en)
|
1997-01-31 |
1999-04-06 |
Depotech Corporation |
Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
CN101818145A
(zh)
|
1998-03-20 |
2010-09-01 |
联邦科学和工业研究组织 |
控制基因表达
|
|
EP1071753A2
(en)
|
1998-04-20 |
2001-01-31 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
|
|
US6043352A
(en)
|
1998-08-07 |
2000-03-28 |
Isis Pharmaceuticals, Inc. |
2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides
|
|
WO2000026342A1
(en)
|
1998-10-30 |
2000-05-11 |
Northwestern University |
Method of interfering with cell proliferation
|
|
US7098192B2
(en)
|
1999-04-08 |
2006-08-29 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of STAT3 expression
|
|
DK1218504T3
(da)
|
1999-09-21 |
2007-11-12 |
Genetics Inst Llc |
GL50 molekyler og anvendelser deraf
|
|
HK1047109A1
(zh)
|
1999-10-15 |
2003-02-07 |
University Of Massachusetts |
作为指定基因干预工具的rna干预轨迹基因
|
|
RU2002112751A
(ru)
|
1999-11-12 |
2004-02-27 |
Файброджен, Инк. (Us) |
Рекомбинантные желатины
|
|
US6680068B2
(en)
|
2000-07-06 |
2004-01-20 |
The General Hospital Corporation |
Drug delivery formulations and targeting
|
|
DE10122140A1
(de)
|
2001-05-08 |
2002-11-28 |
Apotech Res & Dev Ltd |
Rekombinante Fusionsproteine und deren Trimere
|
|
WO2002097114A2
(en)
|
2001-05-29 |
2002-12-05 |
Sirna Therapeutics, Inc. |
Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv
|
|
US20040019001A1
(en)
|
2002-02-20 |
2004-01-29 |
Mcswiggen James A. |
RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA
|
|
EP1399189A1
(en)
|
2001-06-11 |
2004-03-24 |
Universite De Montreal |
Compositions and methods for enhancing nucleic acid transfer into cells
|
|
JP5170934B2
(ja)
|
2001-08-16 |
2013-03-27 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
改良ｄｎａリポフェクションならびに／または徐放性プロドラッグおよび薬物療法のための試薬の合成と使用
|
|
US7390885B2
(en)
|
2001-11-26 |
2008-06-24 |
Cell Matrix, Inc. |
Humanized collagen antibodies and related methods
|
|
US20050008617A1
(en)
|
2002-09-28 |
2005-01-13 |
Massachusetts Institute Of Technology |
Compositions and methods for delivery of short interfering RNA and short hairpin RNA
|
|
US20040208921A1
(en)
|
2003-01-14 |
2004-10-21 |
Ho Rodney J. Y. |
Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymphoid tissues
|
|
JP4939926B2
(ja)
|
2003-02-14 |
2012-05-30 |
アノシス・インコーポレーテッド |
抗体を生成し抗体レパートリーをスクリーニングするための方法とコンパウンド
|
|
MXPA06011526A
(es)
|
2004-04-06 |
2007-03-21 |
Novimmune Sa |
Metodos de tratamiento de enfermedades autoinmunes e inflamatorias.
|
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
|
US20070014788A1
(en)
|
2004-12-13 |
2007-01-18 |
Novo Nordisk A/S |
Laminin-5 modulators and uses thereof
|
|
CA2504279A1
(en)
|
2005-04-15 |
2006-10-15 |
University Of Saskatchewan |
Materials and method of modulating the immune response using t helper-antigen presenting cells
|
|
US20070292866A1
(en)
*
|
2005-12-08 |
2007-12-20 |
Ambergen, Inc. |
Diagnosing human diseases by detecting DNA methylation changes
|
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
|
JP2009536222A
(ja)
|
2006-05-05 |
2009-10-08 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
Ｐｃｓｋ９の発現を調節するための化合物および方法
|
|
CN101437485A
(zh)
|
2006-05-09 |
2009-05-20 |
高露洁-棕榄公司 |
口腔护理方案
|
|
KR101560844B1
(ko)
|
2007-06-04 |
2015-10-15 |
벤-구리온 유니버시티 오브 더 네게브 리서치 앤드 디벨럽먼트 어쏘러티 |
트라이-아릴계 화합물 및 이를 포함하는 조성물
|
|
GB0711858D0
(en)
|
2007-06-19 |
2007-07-25 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US20100298409A1
(en)
|
2007-09-17 |
2010-11-25 |
Intradigm Corporation |
Compositions comprising stat3 sirna and methods of use thereof
|
|
KR101810799B1
(ko)
|
2008-02-01 |
2017-12-19 |
더 제너럴 하스피탈 코포레이션 |
의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
|
|
WO2009100446A1
(en)
|
2008-02-07 |
2009-08-13 |
Terapio, Llc |
Compositions for delivery of cargo such as drugs proteins and/or genetic materials
|
|
FR2928926B1
(fr)
|
2008-03-18 |
2015-08-21 |
Centre Nat Rech Scient |
Polynucleotides et polypeptides chimeriques permettant la secretion d'un polypeptide d'interet en association avec des exosomes et leur utilisation pour la production de compositions immunogenes
|
|
EP2313435A4
(en)
|
2008-07-01 |
2012-08-08 |
Aveo Pharmaceuticals Inc |
FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) BINDING PROTEINS
|
|
WO2010056337A2
(en)
|
2008-11-12 |
2010-05-20 |
Caris Mpi, Inc. |
Methods and systems of using exosomes for determining phenotypes
|
|
US20130053426A1
(en)
|
2009-04-17 |
2013-02-28 |
Yiqi Seow |
Composition For Delivery Of Genetic Material
|
|
KR20120081972A
(ko)
|
2009-07-02 |
2012-07-20 |
아이티에이치 임뮨 세라피 홀딩스 에이비 |
엑소좀에 기초한 암의 치료
|
|
PT2769737T
(pt)
|
2009-07-20 |
2017-06-29 |
Bristol Myers Squibb Co |
Combinação de um anticorpo anti-ctla4 com etopósido para o tratamento sinérgico de doenças proliferativas
|
|
US8889394B2
(en)
|
2009-09-07 |
2014-11-18 |
Empire Technology Development Llc |
Multiple domain proteins
|
|
US20130029339A1
(en)
|
2009-09-09 |
2013-01-31 |
The General Hospital Corporation |
Use of microvesicles in analyzing kras mutations
|
|
US8518405B2
(en)
|
2009-10-08 |
2013-08-27 |
The University Of North Carolina At Charlotte |
Tumor specific antibodies and uses therefor
|
|
WO2011127136A1
(en)
*
|
2010-04-06 |
2011-10-13 |
University Of Chicago |
Composition and methods related to modification of 5-hydroxymethylcytosine (5-hmc)
|
|
WO2011149046A1
(ja)
|
2010-05-28 |
2011-12-01 |
独立行政法人国立がん研究センター |
膵癌治療剤
|
|
AU2011278931A1
(en)
|
2010-07-16 |
2013-03-07 |
Epeius Biotechnologies Corporation |
Targeted nanoparticles for cancer and other disorders
|
|
CN102372773B
(zh)
|
2010-08-11 |
2013-06-05 |
中国科学院生物物理研究所 |
人膀胱癌肿瘤标志物及其抗体和应用
|
|
US20120107317A1
(en)
|
2010-10-27 |
2012-05-03 |
The University Of Hong Kong |
Use of cytoplasmic c-myc for regulating immune responses
|
|
WO2012087241A1
(en)
|
2010-12-20 |
2012-06-28 |
Agency For Science, Technology And Research |
Method of purifying exosomes
|
|
WO2012112315A2
(en)
|
2011-02-20 |
2012-08-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for diagnosis of kawasaki disease
|
|
ITRM20110403A1
(it)
|
2011-07-28 |
2013-01-29 |
Ospedale Pediatrico Bambino Gesu |
Microvescicole isolate da cellule mesenchimali come agenti immunosoppressori.
|
|
GB201121069D0
(en)
|
2011-12-07 |
2012-01-18 |
Isis Innovation |
Delivery system
|
|
RU2664698C2
(ru)
|
2011-12-13 |
2018-08-21 |
Энджинеик Молекьюлар Деливери Пти Лтд |
Полученные из бактерий интактные мини-клетки для доставки лекарственных средств к опухолям мозга
|
|
AU2013229764A1
(en)
|
2012-03-09 |
2014-09-25 |
Massachusetts Institute Of Technology |
Adhesion signatures
|
|
US20130247924A1
(en)
|
2012-03-23 |
2013-09-26 |
Mark Scatterday |
Electronic cigarette having a flexible and soft configuration
|
|
ES3039913T3
(en)
|
2012-05-09 |
2025-10-27 |
Gradalis Inc |
Bi-functional short-hairpin rna (bi-shrna) specific for single-nucleotide kras mutations
|
|
US20150125950A1
(en)
|
2012-05-18 |
2015-05-07 |
Agency For Science, Technology And Research (A*Sta (A*Star) |
Umbilical cord mesenchymal stem cell exosomes
|
|
EP2687219A1
(en)
|
2012-07-18 |
2014-01-22 |
Universität Duisburg-Essen |
Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
|
|
US20150176073A1
(en)
|
2012-07-18 |
2015-06-25 |
Exosome Diagnostics, Inc. |
Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
|
|
AU2013315543A1
(en)
|
2012-09-14 |
2015-04-09 |
Dicerna Pharmaceuticals, Inc. |
Methods and compostions for the specific inhibition of MYC by double-stranded RNA
|
|
CN105051192B
(zh)
|
2012-11-13 |
2020-04-17 |
科迪艾克生物科学公司 |
治疗剂的递送
|
|
CA2877847A1
(en)
|
2012-11-29 |
2014-06-05 |
Yeda Research And Development Co. Ltd. |
Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
|
|
AU2014218667A1
(en)
|
2013-02-22 |
2015-10-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds, compositions, methods, and kits relating to telomere extension
|
|
US10150800B2
(en)
|
2013-03-15 |
2018-12-11 |
Zyngenia, Inc. |
EGFR-binding modular recognition domains
|
|
BR112015023275B1
(pt)
|
2013-03-15 |
2022-06-21 |
Board Of Regents, The University Of Texas System |
Método in vitro de detecção de biomarcador de câncer
|
|
EP2801370A1
(en)
|
2013-05-07 |
2014-11-12 |
Fundació Privada Institut d'Investigació Oncològica de Vall Hebron |
Methods and compositions for the treatment of cancer
|
|
US10545133B2
(en)
|
2013-05-13 |
2020-01-28 |
The Johns Hopkins University |
Molecular signatures of invasive cancer subpopulations
|
|
JP2015001694A
(ja)
|
2013-06-18 |
2015-01-05 |
株式会社リコー |
現像装置、プロセスカートリッジ、及び画像形成装置
|
|
WO2015002956A1
(en)
|
2013-07-01 |
2015-01-08 |
Ohio State Innovation Foundation |
Exosome delivery system
|
|
AU2014296887A1
(en)
|
2013-08-02 |
2016-01-28 |
Aduro Biotech Holdings, Europe B.V. |
Combining CD27 agonists and immune checkpoint inhibition for immune stimulation
|
|
GB201317887D0
(en)
|
2013-10-09 |
2013-11-20 |
Reneuron Ltd |
Product
|
|
US9458169B2
(en)
|
2013-11-01 |
2016-10-04 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
CN106459995B
(zh)
|
2013-11-07 |
2020-02-21 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
CA2930665A1
(en)
|
2013-11-18 |
2015-05-21 |
Rubius Therapeutics, Inc. |
Synthetic membrane-receiver complexes
|
|
US9921223B2
(en)
*
|
2013-12-04 |
2018-03-20 |
Board Of Regents, The University Of Texas System |
Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis
|
|
EP3470089A1
(en)
|
2013-12-12 |
2019-04-17 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components
|
|
US20160324986A1
(en)
|
2013-12-27 |
2016-11-10 |
Teloregen, Inc. |
Compositions and methods for providing active telomerase to cells in vivo
|
|
US9745614B2
(en)
|
2014-02-28 |
2017-08-29 |
Nugen Technologies, Inc. |
Reduced representation bisulfite sequencing with diversity adaptors
|
|
EP3125907A4
(en)
*
|
2014-04-01 |
2017-11-29 |
Cornell University |
Use of double-stranded dna in exosomes: a novel biomarker in cancer detection
|
|
US9895312B2
(en)
|
2014-04-08 |
2018-02-20 |
Pablo E. Vivas-Mejia |
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer
|
|
US10513710B2
(en)
|
2014-04-18 |
2019-12-24 |
University Of Massachusetts |
Exosomal loading using hydrophobically modified oligonucleotides
|
|
EP3134546A4
(en)
|
2014-04-24 |
2017-12-06 |
Dana-Farber Cancer Institute, Inc. |
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
|
|
DK3145493T3
(da)
|
2014-05-18 |
2022-10-31 |
Childrens Medical Center |
Fremgangsmåder og sammensætninger vedrørende exosomer
|
|
EP3158056B1
(en)
|
2014-06-20 |
2021-10-06 |
Rutgers, the State University of New Jersey |
Single cell-derived organoids
|
|
GB201413357D0
(en)
|
2014-07-28 |
2014-09-10 |
Philogen Spa |
Antibodies for treatment and diagnosis
|
|
KR20230128139A
(ko)
|
2014-10-24 |
2023-09-01 |
아스트라제네카 아베 |
조합물
|
|
BR112017008959A2
(pt)
|
2014-10-29 |
2018-01-16 |
Seattle Genetics, Inc. |
método para tratamento de uma doença.
|
|
GB201421094D0
(en)
|
2014-11-27 |
2015-01-14 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Culture medium
|
|
US10697965B2
(en)
*
|
2015-03-02 |
2020-06-30 |
INSERM (INSITUT NATIONAL de la SANTE ET de la RECHERCHE MEDICALE) |
Method for treating and prognosing cancer
|
|
WO2016145030A1
(en)
|
2015-03-11 |
2016-09-15 |
Providence Health & Services-Oregon |
Compositions and methods for enhancing the efficacy of cancer therapy
|
|
EP3736287A1
(en)
|
2015-05-11 |
2020-11-11 |
The Johns Hopkins University |
Autoimmune antibodies for use in inhibiting cancer cell growth
|
|
US20180135012A1
(en)
|
2015-05-13 |
2018-05-17 |
Rubius Therapeutics, Inc. |
Membrane-receiver complex therapeutics
|
|
WO2016185481A2
(en)
|
2015-05-20 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
|
WO2016187717A1
(en)
|
2015-05-26 |
2016-12-01 |
Exerkine Corporation |
Exosomes useful for genome editing
|
|
EP3307890A1
(en)
|
2015-06-10 |
2018-04-18 |
Board of Regents, The University of Texas System |
Use of exosomes for the treatment of disease
|
|
WO2016208673A1
(ja)
|
2015-06-25 |
2016-12-29 |
学校法人早稲田大学 |
コラーゲン様構造を有する重合ペプチド及びゲル
|
|
HRP20230865T1
(hr)
|
2015-07-31 |
2023-11-10 |
Exotropin, Llc |
Kompozicije egzosoma i postupci za njihovu pripremu i primjenu za reguliranje i kondicioniranje kože i kose
|
|
RU2018105118A
(ru)
|
2015-08-21 |
2019-09-23 |
Пфайзер Инк. |
Терапевтические наночастицы, содержащие терапевтический агент, и способы их получения и применения
|
|
WO2017040686A1
(en)
|
2015-09-01 |
2017-03-09 |
University Of Miami |
Identification of circulating cancer associated fibroblasts
|
|
US10508143B1
(en)
|
2015-10-30 |
2019-12-17 |
Aleta Biotherapeutics Inc. |
Compositions and methods for treatment of cancer
|
|
US20170119682A1
(en)
|
2015-11-02 |
2017-05-04 |
Tigenix, S.A.U. |
Mesenchymal stem cell-derived exosomes and their uses
|
|
US20170121685A1
(en)
|
2015-11-02 |
2017-05-04 |
Tigenix S.A.U. |
Mesenchymal stem cell-derived exosomes and their uses
|
|
EP3371211B1
(en)
|
2015-11-04 |
2025-01-01 |
Icahn School of Medicine at Mount Sinai |
Rho-associated protein kinase ("rock") inhibitor for treating tumors and cancer, and identifying candidate subjects for such treatment
|
|
BR112018008971A2
(pt)
|
2015-11-06 |
2018-11-27 |
Crispr Therapeutics Ag |
materiais e métodos para tratamento de doença de armazenamento de glicogênio tipo 1a
|
|
WO2017087560A1
(en)
*
|
2015-11-16 |
2017-05-26 |
Progenity, Inc. |
Nucleic acids and methods for detecting methylation status
|
|
WO2017091702A1
(en)
|
2015-11-25 |
2017-06-01 |
The Methodist Hospital System |
Telomere extension and anti-inflammatory agents for cell regeneration
|
|
EP4212166A1
(en)
|
2015-12-03 |
2023-07-19 |
Juno Therapeutics, Inc. |
Compositions and methods for reducing immune responses against cell therapies
|
|
JP2017120263A
(ja)
|
2015-12-25 |
2017-07-06 |
株式会社特殊免疫研究所 |
腫瘍由来の微小胞マーカーによる薬物感受性予測方法
|
|
EP3397264A4
(en)
|
2015-12-30 |
2019-06-05 |
The Regents of The University of California |
METHOD FOR IMPROVED PREPARATION AND INSULATION OF CELL-DERIVED VESICLES
|
|
WO2017139694A1
(en)
|
2016-02-12 |
2017-08-17 |
Nantomics, Llc |
High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies
|
|
KR20180118175A
(ko)
|
2016-03-04 |
2018-10-30 |
노파르티스 아게 |
다중 키메라 항원 수용체 (car) 분자를 발현하는 세포 및 그에 따른 용도
|
|
CA3017586A1
(en)
|
2016-03-15 |
2017-09-21 |
Codiak Biosciences, Inc. |
Therapeutic membrane vesicles
|
|
EP3440090B1
(en)
|
2016-04-06 |
2022-09-28 |
Ohio State Innovation Foundation |
Rna ligand-displaying exosomes for specific delivery of therapeutics to cell by rna nanotechnology
|
|
ES3002715T3
(en)
*
|
2016-04-14 |
2025-03-07 |
Guardant Health Inc |
Methods for early detection of cancer
|
|
TWI910495B
(zh)
|
2016-05-13 |
2026-01-01 |
美商再生元醫藥公司 |
藉由投予pd-1抑制劑治療皮膚癌之方法
|
|
JP2019519516A
(ja)
|
2016-05-18 |
2019-07-11 |
モデルナティーエックス， インコーポレイテッド |
がんの治療のためのｍＲＮＡ併用療法
|
|
EP3439666A4
(en)
|
2016-05-20 |
2019-12-11 |
The University of Chicago |
NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY, PHOTODYNAMIC THERAPY, IMMUNOTHERAPY AND ALL COMBINATIONS THEREOF
|
|
GB201609216D0
(en)
|
2016-05-25 |
2016-07-06 |
Evox Therapeutics And Isis Innovation Ltd |
Exosomes comprising therapeutic polypeptides
|
|
KR20190039115A
(ko)
|
2016-07-05 |
2019-04-10 |
더 존스 홉킨스 유니버시티 |
암을 치료하기 위한 crispr/cas9-기반 조성물 및 방법
|
|
TWI601741B
(zh)
|
2016-07-11 |
2017-10-11 |
財團法人國家衛生研究院 |
利用前列腺素受體ｅｐ４－拮抗劑誘導幹細胞製造含有高囊泡含物之外泌體囊泡的方法及其應用
|
|
SG11201900344YA
(en)
|
2016-07-15 |
2019-02-27 |
Novartis Ag |
Treatment and prevention of cytokine release syndrome using a chimeric antigen receptor in combination with a kinase inhibitor
|
|
US20190226031A1
(en)
*
|
2016-09-02 |
2019-07-25 |
Fujifilm Wako Pure Chemical Corporation |
Method for amplifying methylated dna, method for determining methylation of dna, and method for determining cancer
|
|
JP2019534041A
(ja)
|
2016-10-06 |
2019-11-28 |
トランスジェネックス ナノバイオテック、インコーポレイテッド |
がん幹細胞（ｃｓｃ）増大のための方法
|
|
JP2018059865A
(ja)
|
2016-10-07 |
2018-04-12 |
株式会社特殊免疫研究所 |
微小胞マーカーによる抗ｃｄ２０抗体医薬品に対する薬物感受性の予測方法
|
|
AU2018239339A1
(en)
|
2017-03-23 |
2019-10-03 |
Penn State Research Foundation |
Method for diagnosing or monitoring conditions characterized by abnormal temporal variations method of normalizing epigenetic data to compensate for temporal variations
|
|
CN107034188B
(zh)
|
2017-05-24 |
2018-07-24 |
中山大学附属口腔医院 |
一种靶向骨的外泌体载体、CRISPR/Cas9基因编辑系统及应用
|
|
GB202209539D0
(en)
|
2017-06-13 |
2022-08-10 |
Bostongene Corp |
Systems and methods for identifying cancer treatments from normalized biomarker scores
|
|
JP2020527340A
(ja)
|
2017-06-30 |
2020-09-10 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
セルフリーｄｎａ中のｄｎａメチル化を評価するための方法およびシステム
|
|
US20210369858A1
(en)
|
2017-08-16 |
2021-12-02 |
Board Of Regents, The University Of Texas System |
Use of exosomes for targeted delivery of therapeutic agents
|
|
JP2021503077A
(ja)
|
2017-11-09 |
2021-02-04 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
細胞外小胞タンパク質、ならびに癌診断、療法に対する応答予測、および治療をするためのそれらの使用
|
|
CN111527199A
(zh)
|
2017-11-16 |
2020-08-11 |
得克萨斯大学体系董事会 |
用于制备来源于msc的外泌体的方法
|
|
AU2018386215B2
(en)
|
2017-12-15 |
2024-11-28 |
Board Of Regents, The University Of Texas System |
Methods and compositions for treating cancer using exosomes-associated gene editing
|
|
CN111655271B
(zh)
|
2017-12-28 |
2025-09-23 |
隆萨销售股份公司 |
用于免疫肿瘤学和抗炎疗法的外来体
|
|
US11512315B2
(en)
|
2018-02-12 |
2022-11-29 |
Codiak Biosciences, Inc. |
Methods and compositions for macrophage polarization
|
|
CA3093856A1
(en)
|
2018-03-12 |
2019-09-19 |
Board Of Regents, The University Of Texas System |
Immuno-exosomes and methods of use thereof
|
|
AU2019243179B2
(en)
|
2018-03-28 |
2025-09-18 |
Board Of Regents, The University Of Texas System |
Use of exosomes for targeted delivery of therapeutic agents
|
|
EP3775258A4
(en)
|
2018-03-28 |
2022-01-26 |
Board of Regents, The University of Texas System |
IDENTIFICATION OF EPIGENETIC ALTERATIONS IN DNA ISOLATED FROM EXOSOMES
|
|
WO2019199803A1
(en)
|
2018-04-09 |
2019-10-17 |
Board Of Regents, The University Of Texas System |
Therapeutic targeting of oncogenes using exosomes
|
|
US20210115449A1
(en)
|
2018-04-19 |
2021-04-22 |
Board Of Regents, The University Of Texas System |
Therapeutic modulation of tumor suppressors using exosomes
|
|
JP2022505032A
(ja)
|
2018-10-16 |
2022-01-14 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
腫瘍オルガノイドを産生するための組成物および腫瘍オルガノイドを産生する方法
|
|
CN113507935A
(zh)
|
2018-10-16 |
2021-10-15 |
得克萨斯州大学系统董事会 |
用于诊断和治疗癌症及其他疾病的对致病性胞外基质的鉴定和靶向
|
|
US20200123258A1
(en)
|
2018-10-23 |
2020-04-23 |
Board Of Regents, The University Of Texas System |
Targeting b cells to enhance response to immune checkpoint blockade
|
|
EP3890802A4
(en)
|
2018-12-08 |
2023-03-22 |
Board of Regents, The University of Texas System |
IDENTIFICATION AND TARGETING OF TUMOR-FOMOTING CARCINOMA ASSOCIATED WITH FIBROBLAST FOR DIAGNOSIS AND TREATMENT OF CANCER AND OTHER DISEASES
|
|
US20220136011A1
(en)
|
2019-02-08 |
2022-05-05 |
Board Of Regents, The University Of Texas System |
Telomerase-containing exosomes for treatment of diseases associated with aging and age-related organ dysfunction
|
|
EP3921325A4
(en)
|
2019-02-08 |
2022-11-23 |
Board of Regents, The University of Texas System |
ISOLATION AND DETECTION OF AN EXOSOME-ASSOCIATED MICROBIOME FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
|
|
CN114641310A
(zh)
|
2019-06-21 |
2022-06-17 |
德克萨斯大学系统董事会 |
治疗癌症和其他疾病的靶向α3β1整合素
|
|
KR20220124170A
(ko)
|
2019-12-05 |
2022-09-13 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
간 섬유증 및 섬유증 관련 기타 질환에 대한 엑소좀 기반 치료요법
|
|
WO2021158966A1
(en)
|
2020-02-05 |
2021-08-12 |
Board Of Regents, The University Of Texas System |
Diagnostic and prognostic utility of exosomes in immunotherapy
|
|
US20230372468A1
(en)
|
2020-03-23 |
2023-11-23 |
Board Of Regents, The University Of Texas System |
Compositions and methods for targeting coronavirus using lipid vesicles including exosomes
|
|
WO2022032238A1
(en)
|
2020-08-07 |
2022-02-10 |
Board Of Regents, The University Of Texas System |
Methods and compositions for pancreatic cancer evaluation and treatment
|